미림진, 2023 국가신약개발사업 R&D 워크샵 우수 포스터로 지정 / MirimGENE, Designation of an excellent poster at the 2023 KDDF R&D Workshop
POSTED ON February 06, 2023
1Mirim
Jin, CEO of MirimGENE,
gave a presentation on the topic of Novel antibody candidate for Rheumatoid Arthritis at the 2023 Korea Drug Development Porject
Fund (KDDF)
R&D Workshop held in Yeoju.
Also, on this day, MirimGENE's
poster was designated as an excellent poster.
